Margate, United Kingdom

Wolfgang Schmidt

This inventor holds 1 USPTO granted patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wolfgang Schmidt. Retrieved from https://idiyas.com/inventor/wolfgang-schmidt-4uwz5biq

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Wolfgang Schmidt: Innovator in Radiolabeled Compounds

Introduction

Wolfgang Schmidt is a notable inventor based in Margate, GB. He has made significant contributions to the field of radiolabeled compounds, which are essential for medical imaging and research.

Latest Patents

Wolfgang Schmidt holds a patent for radiolabeled compounds. The present invention relates to radiolabeled compounds of formula I wherein either A, B, R, or R is labeled with a radionuclide selected from H, C, and F. This innovation is particularly useful for imaging alpha-synuclein and/or Abeta deposits in mammals.

Career Highlights

Wolfgang Schmidt is associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His work focuses on advancing medical imaging techniques through innovative compounds.

Collaborations

Wolfgang has collaborated with notable colleagues, including Edilio Borroni and Luca Claudio Gobbi. Their combined expertise contributes to the success of their projects and innovations.

Conclusion

Wolfgang Schmidt's work in radiolabeled compounds showcases his dedication to advancing medical imaging technology. His contributions are vital for future research and applications in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…